Showing results (11-20 of 2,025) with videos related to
Sort By:
Pageof 203
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1994
Differential effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedureC P Faiman, E Viu, P Skolnick, et al.Neurobiology of Learning and Memory|August 10, 2000
Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learningE Viu, A Zapata, J Capdevila, et al.Psychopharmacology|January 1, 1987
Environmentally-induced modification of the benzodiazepine/GABA receptor coupled chloride ionophoreR Trullas, H Havoundjian, N Zamir, et al.European Journal of Pharmacology|November 6, 1990
Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complexJ T Winslow, T R Insel, R Trullas, et al.Psychopharmacology|January 1, 1992
Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complexP Skolnick, R Miller, A Young, et al.European Journal of Pharmacology|October 22, 1991
1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal modelsR Trullas, T Folio, A Young, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acidG Nowak, R Trullas, R T Layer, et al.Pharmacopsychiatry|January 1, 1996
Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depressionP Skolnick, R T Layer, P Popik, et al.The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cellsE Viu, A Zapata, J L Capdevila, et al.Amino Acids|October 10, 2002
Modulation of glutamate receptors: strategies for the development of novel antidepressantsP SkolnickPageof 203